SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CELGENE CORPORATION
(NQNM:CELG Last Sale: 149.64 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (CELG : $149.64)
$69,254 million Market Cap at September 12, 2013
Employs 4,180.
Drugs SubIndustry up .00% / Health Industry up .00% Today
86 Morris Avenue Research Report Earnings Snapshot - Last 01/29/19
Summit, NJ 07901 Fact Sheet
Phone: 908-673-9000 Financial Statements
Peer Comparison
Annual Reports

Robert J. Hugin, Chmn./CEO/Pres., Perry A. Karsen, COO, Jacqualyn A. Fouse, CFO
Develops a range of immunotherapeutic drugs designed to control serious disease states. Revlimid capsule for a rare blood cancer approved by FDA December 28, 2005. Acquired PHARMION CORP (Q:PHRM) March 8, 2008 for $2.9 billion in cash and stock, $72 per share. Acquired ABRAXIS BIOSCIENCE INC (Q:ABII) October 15, 2010 for $2.9 billion in cash and stock, issuing 10.6 million shares, and paying 0.2617 CELG, $58 cash, and 1 tradeable Contingent Value Right (CVR) per ABII, under agreement of June 30, 2010.
Historical Charts    Technical Analysis
No Historical Data available for CELG

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CELG $149.64 $ 0 $148 $150.93 1,698,425 $71.23 $151 462,801
Rights CELGZ $8.2 $ 0 $8.15 $8.26 16,873 $2.29 $9.49 1
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $69,253,542

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
24-FEB-06 CELG Split 2 for 1
22-OCT-04 CELG Split 2 for 1
14-APR-00 CELG Split 3 for 1

A376
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex